Alexander Blair Wilson
CIK: 0001979602
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AEON Biopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Mar 4, 2026AEON
AEON Biopharma, Inc.
Award(A)Direct1.3M shares- - Feb 17, 2026AEON
AEON Biopharma, Inc.
Award(A)Direct862.5K shares- - May 21, 2025AEON
AEON Biopharma, Inc.
Award(A)DirectRestricted Stock Units
1.3M shares- - Aug 31, 2024AEON
AEON Biopharma, Inc.
Award(A)Direct180.1K shares-
1-4 of 4 transactions
About Wilson Alexander Blair
Wilson Alexander Blair (SEC CIK 0001979602) files insider reports with the SEC as CLO, CSO, and Corp Secretary of AEON Biopharma, Inc. (AEON).
Signal8 holds 3 ownership filings by Wilson Alexander Blair, all Form 4s, filed between Sep 4, 2024 and Mar 5, 2026. Those filings report 4 transactions, from Aug 31, 2024 to Mar 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Wilson Alexander Blair's filings is in IRVINE, CA.
Recent filings by Wilson Alexander Blair
Other insiders filing for AEON Biopharma, Inc. (AEON)
- LYNCH TIMOTHY P, 10% Owner
- Thunen Shelley B, Director
- PALMISANO ROBERT J, Director
- Forth Marc, Director
- FISCHER JOST, Director
- Carter Eric G, Director